Patent: 5,846,534
✉ Email this page to a colleague
Summary for Patent: 5,846,534
Title: | Antibodies to the antigen campath-1 |
Abstract: | An antibody is produced, which will bind effectively with the antigen Campath-1, and which has at least one complementarity determining region of rat origin, as identified in FIG. 2, which may be combined with a range of different foreign variable domain framework regions as desired, including framework regions of human origin. |
Inventor(s): | Waldmann; Herman (Cambridge, GB), Clark; Michael R. (Cambridge, GB), Winter; Gregory P. (Cambridge, GB), Riechmann; Lutz (La Jolla, CA) |
Assignee: | British Technology Group Limited (London, GB) |
Application Number: | 08/235,705 |
Patent Claims: | see list of patent claims |
Details for Patent 5,846,534
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 05/07/2001 | ⤷ Try a Trial | 2015-12-08 |
Genzyme Corporation | LEMTRADA | alemtuzumab | Injection | 103948 | 11/14/2014 | ⤷ Try a Trial | 2015-12-08 |
Genzyme Corporation | CAMPATH | alemtuzumab | Injection | 103948 | 10/12/2004 | ⤷ Try a Trial | 2015-12-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 5,846,534
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | E95068 | ⤷ Try a Trial |
Australia | 3062689 | ⤷ Try a Trial |
Australia | 618989 | ⤷ Try a Trial |
Canada | 1339198 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |